Korro Bio Balance Sheet Health
Financial Health criteria checks 6/6
Korro Bio has a total shareholder equity of $179.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $243.5M and $63.9M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$137.00m |
| Equity | US$179.63m |
| Total liabilities | US$63.91m |
| Total assets | US$243.54m |
Financial Position Analysis
Short Term Liabilities: KRRO's short term assets ($152.8M) exceed its short term liabilities ($13.6M).
Long Term Liabilities: KRRO's short term assets ($152.8M) exceed its long term liabilities ($50.3M).
Debt to Equity History and Analysis
Debt Level: KRRO is debt free.
Reducing Debt: KRRO has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: KRRO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: KRRO has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 26.4% each year.